ArticleBMC cardiovascular disorders2026
Variability of SBP and cardiovascular outcomes in hypertensive patients.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundVisit-to-visit variability (VVV) in blood pressure (BP) has been linked to adverse cardiovascular outcomes, but the number of measurements needed for reliable assessment is unclear. This study aimed to determine the minimum number of systolic BP (SBP) readings required to quantify VVV and predict major adverse cardiovascular events (MACE) in patients with hypertension.
methodsWe have conducted a multicenter retrospective cohort study using electronic health records of the Korea University Medical Center database. Overall, data from 4,480 patients with hypertension who had more than nine BP readings during a maximum period of 2 years were identified. This study used the coefficient of variation (CV) for analysis of variability and its correlation with MACE over a 3-year follow-up.
resultsThe area under the receiver-operating characteristic curve (AUC) for MACE prediction plateaued at around 0.60 with five readings, indicating minimal gain with additional readings. The mean CV that best predicted the 3-year MACE for five SBP readings was 8.2. Patients with high SBP variability (CV > 8, based on five readings) had a hazard ratio of 1.89 (95% confidence interval, 1.48–2.41) for 3-year MACE, compared with those with low SBP variability. In multivariable analysis, high SBP variability remained an independent risk factor of MACE.
conclusionTo conclude, a minimum of five SBP readings appear sufficient to estimate visit-to-visit variability associated with cardiovascular risk in patients with hypertension. Assessment of SBP variability using routinely collected clinic measurements may complement conventional risk evaluation, although further validation in broader hypertensive populations is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.